Cargando…
Advances in HBV infection and replication systems in vitro
BACKGROUND: Hepatitis B virus (HBV) is a DNA virus belonging to the Hepadnaviridae family that has limited tissue and species specificity. Due to the persistence of HBV covalently closed circular DNA (cccDNA) in host cells after HBV infection, current antiviral drugs cannot eradicate HBV. Therefore,...
Autores principales: | Xu, Ruirui, Hu, Pingping, Li, Yuwen, Tian, Anran, Li, Jun, Zhu, Chuanlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164799/ https://www.ncbi.nlm.nih.gov/pubmed/34051803 http://dx.doi.org/10.1186/s12985-021-01580-6 |
Ejemplares similares
-
The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing
por: Hu, Pingping, et al.
Publicado: (2023) -
Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation
por: Li, Yuwen, et al.
Publicado: (2019) -
Plerixafor and resatorvid inhibit hepatitis B virus in vitro by upregulating elongation factor Tu GTP-binding domain containing 2
por: Cai, Jinyuan, et al.
Publicado: (2023) -
The Infection Efficiency and Replication Ability of Circularized HBV DNA Optimized the Linear HBV DNA in Vitro and in Vivo
por: Li, Xiaosong, et al.
Publicado: (2015) -
Analysis of dynamic disturbance in blood coagulation function of patients with Coronavirus Disease 2019: A retrospective observational study
por: Chen, Nian, et al.
Publicado: (2020)